BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alharthi J, Latchoumanin O, George J, Eslam M. Macrophages in metabolic associated fatty liver disease. World J Gastroenterol 2020; 26(16): 1861-1878 [PMID: 32390698 DOI: 10.3748/wjg.v26.i16.1861]
URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1861.htm
Number Citing Articles
1
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>Drug Design, Development and Therapy 2020; : 3865 doi: 10.2147/DDDT.S258857
2
Anika Niambi Al-Shura. Metabolic Disorders and Shen in Integrative Cardiovascular Chinese Medicine2021; : 17 doi: 10.1016/B978-0-12-818922-1.00003-9
3
Yu Jung Heo, Sung‐E Choi, Nami Lee, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse modelJournal of Gastroenterology and Hepatology 2021; 36(9): 2592 doi: 10.1111/jgh.15465
4
Shanshan Liu, Jialu Wang, Shujing Wu, Jingya Niu, Ruizhi Zheng, Lizhan Bie, Zhuojun Xin, Shuangyuan Wang, Hong Lin, Zhiyun Zhao, Tiange Wang, Min Xu, Jieli Lu, Yuhong Chen, Yiping Xu, Weiqing Wang, Guang Ning, Yufang Bi, Mian Li, Yu Xu. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysisMetabolism 2021; 120: 154779 doi: 10.1016/j.metabol.2021.154779
5
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor SignalingMetabolites 2020; 10(8): 326 doi: 10.3390/metabo10080326
6
Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Alves Fonseca, Valessa Emanoele Gabriel de Souza, Mário Reis Álvares-da-Silva. Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?Hepatology International 2021; 15(2): 380 doi: 10.1007/s12072-021-10157-y
7
Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, Henning Grønbæk. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?Expert Review of Gastroenterology & Hepatology 2021; 15(1): 51 doi: 10.1080/17474124.2020.1817740